Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Yamashita Health Care Holdings's annualized ROCE % for the quarter that ended in Feb. 2026 was 10.91%.
Yamashita Health Care Holdings (TSE:9265) ROCE % Explanation
ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.
Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.
Yamashita Health Care Holdings ROCE % Related Terms
Yamashita Health Care Holdings ROCE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
(1) Note:
The EBIT data used here is four times the quarterly (Feb. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yamashita Health Care Holdings (TSE:9265) has a ROCE % of 10.91% as of Feb. 2026.
Is Yamashita Health Care Holdings' ROCE % too high?
Yamashita Health Care Holdings' current ROCE % is 10.91%. The Medical Distribution industry median ROCE % is 9.01. Yamashita Health Care Holdings' value of 10.91% is 21.2% above this industry median. Overall, Yamashita Health Care Holdings has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yamashita Health Care Holdings' ROCE % compare to MCK and COR?
Yamashita Health Care Holdings' ROCE % of 10.91% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 9.01. Yamashita Health Care Holdings' value of 10.91% is 21.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Distribution company?
The median ROCE % among Medical Distribution companies is 9.01, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yamashita Health Care Holdings's current ROCE % of 10.91% is 21.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 9.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yamashita Health Care Holdings's current ROCE % is 10.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yamashita Health Care Holdings stock overvalued right now?
Based on GuruFocus' analysis, Yamashita Health Care Holdings (TSE:9265) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,955.01, compared to a current price of 円3,400.00 — trading 15.1% above its estimated fair value. The current ROCE % is 10.91% and 21.2% above the Medical Distribution industry median of 9.01. Yamashita Health Care Holdings' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Yamashita Health Care Holdings (TSE:9265), the current ROCE % is 10.91% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yamashita Health Care Holdings (TSE:9265) Overvalued in 2026?
Based on GuruFocus' analysis, Yamashita Health Care Holdings stock appears to be overvalued.
The current stock price of 円3,400.00 is trading 15.1% above its estimated GF Value™ of 円2,955.01.
GuruFocus considers Yamashita Health Care Holdings to be Modestly Overvalued.
Key valuation signals for TSE:9265:
ROCE %: 10.91%
GF Value™: 円2,955.01 vs. price of 円3,400.00 (15.1% above fair value)
Industry Position: 21.2% above the Medical Distribution median
No single metric tells the full story. See the TSE:9265 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yamashita Health Care Holdings Inc is a Japan-based medical equipment wholesale company that sells medical equipment for medical institutions within the Kyushu area. The company is also engaged in the manufacture, sale, leasing, and rental of optical instruments, physicochemical instruments, analytical instruments, measuring instruments, health equipment, exercise equipment, nursing care equipment, animal medical equipment, and veterinary drugs.
64GF Score
Get the complete analysis for TSE:9265
ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9265 has been successfully added to your 
